BRAIN AGING - A RISK FACTOR OF NEURODEGENERATIVE DISORDERS AND A TARGET FOR THERAPEUTIC INTERVENTION

被引：4
|
作者：
MULLER, WE
PEDIGO, NW
机构：
[1] UNIV KENTUCKY,AB CHANDLER MED CTR,DEPT PHARMACOL,LEXINGTON,KY 40536
[2] UNIV KENTUCKY,AB CHANDLER MED CTR,DEPT ANESTHESIOL,LEXINGTON,KY 40536
来源：
LIFE SCIENCES | 1994年 / 55卷 / 25-26期
关键词：
NEURODEGENERATIVE DISEASES; PARKINSONS DISEASE; ALZHEIMERS DISEASE; DEMENTIA; THERAPEUTICS;
D O I：
10.1016/0024-3205(94)00376-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1975 / 1976
页数：2
相关论文
共 50 条
  • [41] Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease
    Shubhada V. Mangrulkar
    Nitu L. Wankhede
    Mayur B. Kale
    Aman B. Upaganlawar
    Brijesh G. Taksande
    Milind J. Umekar
    Md. Khalid Anwer
    Hamad Ghaleb Dailah
    Syam Mohan
    Tapan Behl
    Neurotoxicity Research, 2023, 41 : 708 - 729
  • [42] Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease
    Mangrulkar, Shubhada V. V.
    Wankhede, Nitu L. L.
    Kale, Mayur B. B.
    Upaganlawar, Aman B. B.
    Taksande, Brijesh G. G.
    Umekar, Milind J. J.
    Anwer, Md. Khalid
    Dailah, Hamad Ghaleb
    Mohan, Syam
    Behl, Tapan
    NEUROTOXICITY RESEARCH, 2023, 41 (06) : 708 - 729
  • [43] Unfolding the pleiotropic facades of rosuvastatin in therapeutic intervention of myriads of neurodegenerative disorders
    Husain, Ibraheem
    Khan, Sana
    Khan, Saba
    Madaan, Tushar
    Kumar, Sanjeev
    Najmi, Abul K.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (04) : 283 - 291
  • [44] STI1-PRPC AS A POTENTIAL THERAPEUTIC TARGET IN NEURODEGENERATIVE DISORDERS
    Prado, M. A.
    Beraldo, F. H.
    Caetano, F. A.
    Guimaraes, A. L.
    Mohammad, A.
    Ostapchenko, V
    Hajj, G. N.
    Prado, V. F.
    Martins, V. R.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 177 - 177
  • [45] ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders
    Chong, Cheong-Meng
    Ai, Nana
    Lee, Simon Ming-Yuen
    CURRENT DRUG TARGETS, 2017, 18 (04) : 455 - 462
  • [46] Phospholipase D as a Therapeutic Target in Brain Disorders
    Lindsley, Craig W.
    Brown, H. Alex
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (01) : 301 - 302
  • [47] Phospholipase D as a Therapeutic Target in Brain Disorders
    Craig W Lindsley
    H Alex Brown
    Neuropsychopharmacology, 2012, 37 : 301 - 302
  • [48] Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders
    Gediya, Piyush
    Parikh, Palak K.
    Vyas, Vivek K.
    Ghate, Manjunath D.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 216
  • [49] Therapeutic Role and Drug Delivery Potential of Neuroinflammation as a Target in Neurodegenerative Disorders
    Singh, Abhijeet
    Chokriwal, Ankit
    Sharma, Madan Mohan
    Jain, Devendra
    Saxena, Juhi
    Stephen, Bjorn John
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (08): : 1645 - 1655
  • [50] Macrophage-derived extracellular vesicles target inflamed brain and deliver therapeutic proteins for treatment of neurodegenerative disorders
    Batrakova, E., V
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (02) : 336 - 336
12345